Copyright Reports & Markets. All rights reserved.

Asia-Pacific Alzheimer's Disease Diagnostic Market Report 2018

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Alzheimer's Disease Diagnostic Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Early-onset Alzheimer's Market Performance (Volume)
      • 2.1.2 Late-onset Alzheimer's Market Performance (Volume)
      • 2.1.3 Familial Alzheimer's Disease Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Early-onset Alzheimer's Market Performance (Value)
      • 2.1.2 Late-onset Alzheimer's Market Performance (Value)
      • 2.1.3 Familial Alzheimer's Disease Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Clinics Market Performance (Volume)
      • 3.1.2 Hospitals Market Performance (Volume)
      • 3.1.3 Diagnostic Centers Market Performance (Volume)
      • 3.1.4 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Eli Lilly and Company (UK)
      • 4.1.1 Eli Lilly and Company (UK) Profiles
      • 4.1.2 Eli Lilly and Company (UK) Product Information
      • 4.1.3 Eli Lilly and Company (UK) Alzheimer's Disease Diagnostic Business Performance
      • 4.1.4 Eli Lilly and Company (UK) Alzheimer's Disease Diagnostic Business Development and Market Status
    • 4.2 TauRx (Republic of Singapore)
      • 4.2.1 TauRx (Republic of Singapore) Profiles
      • 4.2.2 TauRx (Republic of Singapore) Product Information
      • 4.2.3 TauRx (Republic of Singapore) Alzheimer's Disease Diagnostic Business Performance
      • 4.2.4 TauRx (Republic of Singapore) Alzheimer's Disease Diagnostic Business Development and Market Status
    • 4.3 Alector LLC (US)
      • 4.3.1 Alector LLC (US) Profiles
      • 4.3.2 Alector LLC (US) Product Information
      • 4.3.3 Alector LLC (US) Alzheimer's Disease Diagnostic Business Performance
      • 4.3.4 Alector LLC (US) Alzheimer's Disease Diagnostic Business Development and Market Status
    • 4.4 Accera (US)
      • 4.4.1 Accera (US) Profiles
      • 4.4.2 Accera (US) Product Information
      • 4.4.3 Accera (US) Alzheimer's Disease Diagnostic Business Performance
      • 4.4.4 Accera (US) Alzheimer's Disease Diagnostic Business Development and Market Status
    • 4.5 Treventis Corporation (US)
      • 4.5.1 Treventis Corporation (US) Profiles
      • 4.5.2 Treventis Corporation (US) Product Information
      • 4.5.3 Treventis Corporation (US) Alzheimer's Disease Diagnostic Business Performance
      • 4.5.4 Treventis Corporation (US) Alzheimer's Disease Diagnostic Business Development and Market Status
    • 4.6 Neuro-Bio Ltd (UK)
      • 4.6.1 Neuro-Bio Ltd (UK) Profiles
      • 4.6.2 Neuro-Bio Ltd (UK) Product Information
      • 4.6.3 Neuro-Bio Ltd (UK) Alzheimer's Disease Diagnostic Business Performance
      • 4.6.4 Neuro-Bio Ltd (UK) Alzheimer's Disease Diagnostic Business Development and Market Status
    • 4.7 Cognition Therapeutics (US)
      • 4.7.1 Cognition Therapeutics (US) Profiles
      • 4.7.2 Cognition Therapeutics (US) Product Information
      • 4.7.3 Cognition Therapeutics (US) Alzheimer's Disease Diagnostic Business Performance
      • 4.7.4 Cognition Therapeutics (US) Alzheimer's Disease Diagnostic Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Asia-Pacific Alzheimer's Disease Diagnostic Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Asia-Pacific Alzheimer's Disease Diagnostic Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Asia-Pacific Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Asia-Pacific Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 China Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 China Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 China Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Japan Market Performance for Manufacturers
      • 6.2.1 Japan Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Japan Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Japan Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Japan Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Korea Market Performance for Manufacturers
      • 6.3.1 South Korea Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Korea Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Korea Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Korea Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Taiwan Market Performance for Manufacturers
      • 6.4.1 Taiwan Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Taiwan Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Taiwan Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Taiwan Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 India Market Performance for Manufacturers
      • 6.5.1 India Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 India Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 India Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 India Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Southeast Asia Market Performance for Manufacturers
      • 6.6.1 Southeast Asia Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Southeast Asia Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Southeast Asia Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Southeast Asia Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Australia Market Performance for Manufacturers
      • 6.7.1 Australia Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Australia Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Australia Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Australia Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Alzheimer's Disease Diagnostic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Alzheimer's Disease Diagnostic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Alzheimer's Disease Diagnostic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Alzheimer's Disease Diagnostic Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Asia-Pacific Alzheimer's Disease Diagnostic Market Performance (Sales Point)

    • 7.1 Asia-Pacific Alzheimer's Disease Diagnostic Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Asia-Pacific Alzheimer's Disease Diagnostic Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Asia-Pacific Alzheimer's Disease Diagnostic Price (USD/Unit) by Regions 2013-2018
    • 7.4 Asia-Pacific Alzheimer's Disease Diagnostic Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Asia-Pacific Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 China Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Japan Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Korea Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Taiwan Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 India Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Southeast Asia Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Australia Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Australia Alzheimer's Disease Diagnostic Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Clinics Industry
    • 11.2 Hospitals Industry
    • 11.3 Diagnostic Centers Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Asia-Pacific Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Asia-Pacific Alzheimer's Disease Diagnostic Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 China Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Japan Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Korea Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Taiwan Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 India Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Southeast Asia Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Australia Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Alzheimer's Disease Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Early-onset Alzheimer's Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Late-onset Alzheimer's Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Familial Alzheimer's Disease Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Clinics Sales and and Growth Rate 2019-2024
      • 12.4.3 Hospitals Sales and and Growth Rate 2019-2024
      • 12.4.4 Diagnostic Centers Sales and and Growth Rate 2019-2024
      • 12.4.5 Others Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Asia-Pacific Alzheimer's Disease Diagnostic Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Asia-Pacific Alzheimer's Disease Diagnostic Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Alzheimer's Disease Diagnostic for these regions, from 2012 to 2023 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

    Asia-Pacific Alzheimer's Disease Diagnostic market competition by top manufacturers/players, with Alzheimer's Disease Diagnostic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Eli Lilly and Company (UK)
    TauRx (Republic of Singapore)
    Alector LLC (US)
    Accera (US)
    Treventis Corporation (US)
    Neuro-Bio Ltd (UK)
    Cognition Therapeutics (US)
    ...

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Early-onset Alzheimer's
    Late-onset Alzheimer's
    Familial Alzheimer's Disease

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Alzheimer's Disease Diagnostic for each application, including
    Clinics
    Hospitals
    Diagnostic Centers
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now